TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34620117

Group type: EXPERIMENTAL
Intervention: Metronome-based technique
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard stopwatch-based technique
Number of subjects: 42
Study: 32388868

Group type: EXPERIMENTAL
Intervention: VER group (vitamin E-enriched transgenic maize)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Positive control group (non-GM maize plus exogenous vitamin E)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Negative control group (non-GM maize)
Number of subjects: 360
Study: 34908019

Group type: EXPERIMENTAL
Intervention: Regadenoson
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dipyridamole
Number of subjects: 200
Study: 34515194

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 277
Study: 35179323

Group type: EXPERIMENTAL
Intervention: Darolutamide (600 mg twice daily)
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Darolutamide and Placebo
Number of subjects: 1306
Study: 34692441

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily for 10 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35569564

Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation (NT‐proBNP, troponin T, cystatin C, GDF‐15, IL‐6, CRP)
Number of subjects: 11818

Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation
Number of subjects: 11818
Study: 36050387

Group type: EXPERIMENTAL
Intervention: High-pay-off, geographically targeted lotteries in treated zip codes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control zip codes
Number of subjects: 0
Study: 32124049

Group type: EXPERIMENTAL
Intervention: Loop ileostomy closure
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Questionnaire
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Clinical and radiological diagnosis
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Risk factors
Number of subjects: 216
Study: 34856838

Group type: EXPERIMENTAL
Intervention: Sterile kinesio taping
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standardized postoperative physiotherapy
Number of subjects: 56
Study: 34060988

Group type: EXPERIMENTAL
Intervention: Cuyuxunxi (CYXX) prescription
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 10
Study: 32188697

Group type: EXPERIMENTAL
Intervention: Low-sodium dialysate (135 mM)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional dialysate (140 mM)
Number of subjects: 99
Study: 35339954

Group type: EXPERIMENTAL
Intervention: Individualized and progressive multicomponent exercise program (6 months)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine activities (Control)
Number of subjects: 112
Study: 34961531

Group type: EXPERIMENTAL
Intervention: i-ACT training (3×45 min/week for 6 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: i-ACT training
Number of subjects: 47
Study: 34601551

Group type: EXPERIMENTAL
Intervention: Medium-dose spice diet (MSD) 3.285 g · d‐1 · 2100 kcal‐1 for 4 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: High-dose spice diet (HSD) 6.571 g · d‐1 · 2100 kcal‐1 for 4 weeks
Number of subjects: 63
Study: 33111740

Group type: EXPERIMENTAL
Intervention: Reiki protocol (n=31)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Conventional care (n=59)
Number of subjects: 124
Study: 34213748

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Interventions (MBIs) training for 6 months
Number of subjects: 160
Study: 32060566

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: 50 µg/day VK2
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: 90 µg/day VK2
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Co-supplementation with calcium (500 mg/day) and vitamin D3 (10 µg/day)
Number of subjects: 311
Study: 33438181

Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 837

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 837
Study: 33771659

Group type: EXPERIMENTAL
Intervention: Bio-Oss Collagen
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (untreated sockets)
Number of subjects: 66
Study: 34496821

Group type: EXPERIMENTAL
Intervention: Anterior controllable antedisplacement and fusion (ACAF)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Conventional posterior laminoplasty (LAMP)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: ACAF
Number of subjects: 164

Group type: COMPARATOR
Intervention: LAMP
Number of subjects: 164
Study: 35399221

Group type: EXPERIMENTAL
Intervention: PDCA home nursing (research group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine home nursing (control group)
Number of subjects: 64
Study: 33555266

Group type: EXPERIMENTAL
Intervention: Social support (informational support)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Social support (emotional support)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Perceived health information sensitivity
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Privacy concerns
Number of subjects: 253
Study: 32602966

Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 21
Study: 33503628

Group type: EXPERIMENTAL
Intervention: Genetic underpinnings of psychiatric conditions handout
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Agency-oriented handout focusing on gene-environment interactions
Number of subjects: 417

Group type: COMPARATOR
Intervention: Both handouts
Number of subjects: 417
Study: 35294330

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT) for 16 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combined Training (CT) for 8 weeks after 8 weeks of AT
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control Group (CG) performing low-intensity therapeutic exercises in water
Number of subjects: 52
Study: 33040841

Group type: EXPERIMENTAL
Intervention: Trazodone/gabapentin combination (2.5/25, 10/100, 30/300)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Trazodone/gabapentin combination (10/100)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 29
Study: 32071186

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) troponin T measurement
Number of subjects: 866

Group type: COMPARATOR
Intervention: Presentation at the emergency department (ED)
Number of subjects: 866
Study: 34914338

Group type: EXPERIMENTAL
Intervention: Ascorbic acid 250 mg daily (AA250 arm)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ascorbic acid 500 mg daily (AA500 arm)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No intervention (NI arm)
Number of subjects: 45
Study: 34181225

Group type: EXPERIMENTAL
Intervention: Fish/seafood consumption among food insecure FN participants in eastern regions (Ontario, Quebec/Labrador, Atlantic region)
Number of subjects: 6258

Group type: EXPERIMENTAL
Intervention: Traditional food (TF) consumption including fish/seafood among severely food insecure men
Number of subjects: 6258

Group type: EXPERIMENTAL
Intervention: Fish/seafood as a source of nutrients
Number of subjects: 6258

Group type: EXPERIMENTAL
Intervention: Barriers to fish/seafood access
Number of subjects: 6258
Study: 33065791

Group type: EXPERIMENTAL
Intervention: Xipayi mouth rinse combined with minocycline
Number of subjects: 96

Group type: COMPARATOR
Intervention: Xipayi mouth rinse
Number of subjects: 96
Study: 34996918

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% with epinephrine 1:200,000
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 4 ml DW5
Number of subjects: 52
Study: 33105146

Group type: EXPERIMENTAL
Intervention: Liraglutide (titrated to maximum tolerable dose up to 1.8 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 24
Study: 35599918

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (4000 IU weekly)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 33865797

Group type: EXPERIMENTAL
Intervention: Limited PLND (external iliac nodes)
Number of subjects: 1440

Group type: COMPARATOR
Intervention: Extended PLND (external iliac, obturator fossa and hypogastric nodes)
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: Limited PLND
Number of subjects: 1440

Group type: COMPARATOR
Intervention: Extended PLND
Number of subjects: 1440
Study: 34033265

Group type: EXPERIMENTAL
Intervention: Pregabalin 5 mg/kg/day
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Pregabalin 10 mg/kg/day
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 32176565

Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acid (ω3FA) supplementation for 60 days
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 33522909

Group type: EXPERIMENTAL
Intervention: 2 g of cefazolin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 0
Study: 32299458

Group type: EXPERIMENTAL
Intervention: Myocardial revascularization (CABG)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 600
Study: 36274362

Group type: EXPERIMENTAL
Intervention: Narrow resection margin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRI-based preoperative markers (tumour size > 5 cm, substantial necrosis, non-smooth margins) combined with narrow resection margin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wide resection margin
Number of subjects: 0
Study: 33289350

Group type: EXPERIMENTAL
Intervention: 3 mg FT-4101
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 35565738

Group type: EXPERIMENTAL
Intervention: 50 mg gluten
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 500 mg gluten
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Gluten administration (all doses)
Number of subjects: 15
Study: 33864584

Group type: EXPERIMENTAL
Intervention: EAAA program (Sexual Assault Resistance Education)
Number of subjects: 0
Study: 34529686

Group type: EXPERIMENTAL
Intervention: Anxiety reduction/prevention program
Number of subjects: 64

Group type: COMPARATOR
Intervention: No intervention/treatment as usual
Number of subjects: 64
Study: 35238902

Group type: EXPERIMENTAL
Intervention: AGN-190584
Number of subjects: 323

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 323
Study: 32739415

Group type: EXPERIMENTAL
Intervention: Teaching residents about ACL tear signs during a 2-4 week rotation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Experience of radiologists
Number of subjects: 60
Study: 34272216

Group type: EXPERIMENTAL
Intervention: Personalised health profile
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Structured telephone consultation
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 303
Study: 35392153

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 µg/ml)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sufentanyl (0.4 µg/ml)
Number of subjects: 120
Study: 34449776

Group type: EXPERIMENTAL
Intervention: Postoperative high-load long-duration inspiratory muscle training (40% of baseline maximal inspiratory pressure targeting a load of 80% by the end of 8 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional physiotherapy care (Control group)
Number of subjects: 100
Study: 34470816

Group type: EXPERIMENTAL
Intervention: Healthy Weight Clinic (HWC)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Modified Healthy Weight and Your Child (M-HWYC)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Comparison sites
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Comparison of M-HWYC and HWC
Number of subjects: 407
Study: 32749474

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35188555

Group type: EXPERIMENTAL
Intervention: Tonsillotomy (carbon dioxide laser under local anesthesia)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Tonsillectomy (total tonsil removal under general anesthesia)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Tonsillotomy
Number of subjects: 199

Group type: COMPARATOR
Intervention: Tonsillectomy
Number of subjects: 199
Study: 34840636

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) applied to Jian yu (LI15), Bi nao (LI14), Jian zhen (SI9), and Jian liao (TE14) acupoints, 30 minutes/day, five days a week, for two weeks.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham Electroacupuncture (SEA) applied 15 mm away from Lou gu (SP7), Di ji (SP8), Jiao xin (KI8), and Zhu bin (KI9) acupoints, 30 minutes/day, five days a week, for two weeks.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both EA and SEA groups.
Number of subjects: 34
Study: 34978861

Group type: EXPERIMENTAL
Intervention: Quadpill containing quarter doses of 4 blood pressure drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose monotherapy
Number of subjects: 0
Study: 33558153

Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM)
Number of subjects: 797
Study: 32353035

Group type: EXPERIMENTAL
Intervention: Digital weight management intervention with one-on-one health coaching via app-based video chat
Number of subjects: 683
Study: 35962536

Group type: EXPERIMENTAL
Intervention: Executive function training (25 training sessions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study: 33118831

Group type: EXPERIMENTAL
Intervention: Nomograms predicting overall survival (OS) and cancer-specific survival (CSS) based on independent prognostic factors identified through Cox analyses.
Number of subjects: 1066
Study: 32331020

Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil (AL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paliperidone palmitate (PP)
Number of subjects: 200
Study: 35283036

Group type: EXPERIMENTAL
Intervention: Smart water bottle (HidrateSpark®; Hydrate Inc.)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard dietary recommendations (DR arm)
Number of subjects: 85
Study: 33622057

Group type: EXPERIMENTAL
Intervention: Xanthomonas fragariae strain YL19 inoculation (2×10^8 CFU)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (sterile water)
Number of subjects: 121
Study: 34147611

Group type: EXPERIMENTAL
Intervention: Patients living alone
Number of subjects: 202

Group type: COMPARATOR
Intervention: Patients living with someone else
Number of subjects: 202
Study: 33118603

Group type: EXPERIMENTAL
Intervention: Central Sensitization Inventory (CSI)
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Central Sensitization Inventory Symptom Severity Calculator
Number of subjects: 2620
Study: 35346485

Group type: EXPERIMENTAL
Intervention: Losartan (50 to 100 mg)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard hypotensive treatment (ST)
Number of subjects: 134
Study: 34127486

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) therapy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Child Life (CL) support without VR
Number of subjects: 55

Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 55
Study: 34741544

Group type: EXPERIMENTAL
Intervention: Nurse-led MBSR therapy + regular diabetes education
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular diabetes education
Number of subjects: 100
Study: 34312221

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% occipital nerve block
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33280397

Group type: EXPERIMENTAL
Intervention: Self-applied acupressure in combination with usual treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 160
Study: 33919990

Group type: EXPERIMENTAL
Intervention: Quercetin
Number of subjects: 0
Study: 33331798

Group type: EXPERIMENTAL
Intervention: Nutraceutical (combination of soy isoflavone, black cohosh, chasteberry, and evening primrose oil extracts)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 33223141

Group type: EXPERIMENTAL
Intervention: Higher doses of sevoflurane
Number of subjects: 621

Group type: COMPARATOR
Intervention: Lower doses of sevoflurane
Number of subjects: 621
Study: 33714712

Group type: EXPERIMENTAL
Intervention: Home care training (two additional training sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine training (control group)
Number of subjects: 80
Study: 32321713

Group type: EXPERIMENTAL
Intervention: Integrated risk model including clinical factors, genetic polymorphisms, and circulating biomarkers
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Integrated risk model
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Top risk percentile individuals
Number of subjects: 1591

Group type: COMPARATOR
Intervention: Clinical factors alone
Number of subjects: 1591
Study: 34666606

Group type: EXPERIMENTAL
Intervention: Fatherhood intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Qualitative descriptive content analysis
Number of subjects: 12
Study: 34590118

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Breast milk (subgroup with similar initial gastric volume)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Infant formula
Number of subjects: 16
Study: 34933343

Group type: EXPERIMENTAL
Intervention: RNA sequencing (RNA‐seq)
Number of subjects: 173
Study: 34265446

Group type: EXPERIMENTAL
Intervention: Eosinophilic Esophagitis patients (n=21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Eosinophilic Esophagitis patients (n=20)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Males aged 13 years and older with EoE
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Female EoE patients
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Male EoE patients
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both male and female EoE patients
Number of subjects: 41
Study: 34875098

Group type: EXPERIMENTAL
Intervention: tDCS (anodal over left inferior frontal gyrus)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 23
Study: 33606739

Group type: EXPERIMENTAL
Intervention: Standard intra-abdominal pressure (P10-12, 10-12 mm Hg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Low intra-abdominal pressure (P6-8, 6-8 mm Hg)
Number of subjects: 64
Study: 32232615

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with 106 cfu/mL/kg Lactobacillus acidophilus
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control diet (0 cfu/mL/kg Lactobacillus acidophilus)
Number of subjects: 240
Study: 34378545

Group type: EXPERIMENTAL
Intervention: Iris scan technology
Number of subjects: 699
Study: 33244404

Group type: EXPERIMENTAL
Intervention: Emotional support
Number of subjects: 2064

Group type: EXPERIMENTAL
Intervention: Social network support
Number of subjects: 2064

Group type: COMPARATOR
Intervention: Physical activity
Number of subjects: 2064
Study: 35696706

Group type: EXPERIMENTAL
Intervention: My Surgical Success (MSS)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Digital general health education (HE)
Number of subjects: 133
Study: 34769656

Group type: EXPERIMENTAL
Intervention: Strong Families programme (intervention group, n = 199)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Waitlist/control group (n = 93)
Number of subjects: 292
Study: 32119591

Group type: EXPERIMENTAL
Intervention: lyophilized TAK-003 formulation
Number of subjects: 1002

Group type: COMPARATOR
Intervention: liquid TAK-003 formulation
Number of subjects: 1002
Study: 34980131

Group type: EXPERIMENTAL
Intervention: Camrelizumab plus chemotherapy
Number of subjects: 270

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 270
Study: 32502713

Group type: EXPERIMENTAL
Intervention: Spaced retraining group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 35889878

Group type: EXPERIMENTAL
Intervention: Oligonol
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 32607803

Group type: EXPERIMENTAL
Intervention: DCE‐CT (dynamic contrast‐enhanced computed tomography)
Number of subjects: 36

Group type: COMPARATOR
Intervention: DCE‐MRI (dynamic contrast‐enhanced MRI)
Number of subjects: 36
Study: 34331546

Group type: EXPERIMENTAL
Intervention: imSTROKE
Number of subjects: 611

Group type: COMPARATOR
Intervention: RAPID
Number of subjects: 611
Study: 34232211

Group type: EXPERIMENTAL
Intervention: CURCUGEN, a novel dispersible, 50% curcuminoids-concentrated turmeric extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CURCUGEN
Number of subjects: 0

Group type: COMPARATOR
Intervention: C-95, standard curcumin reference product
Number of subjects: 0
Study: 35932073

Group type: EXPERIMENTAL
Intervention: Nurse-led integrative medicine-based structured education program (4 weeks)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 128
Study: 33423620

Group type: EXPERIMENTAL
Intervention: Exercise training (ET) consisting of aerobic, strengthening and stretching exercises, 2 days/week for 6 weeks in addition to compression therapy (CT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Compression therapy (CT) only
Number of subjects: 24
Study: 32377902

Group type: EXPERIMENTAL
Intervention: His bundle pacing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left bundle branch pacing
Number of subjects: 0
Study: 35432020

Group type: EXPERIMENTAL
Intervention: 8-week online mindfulness intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: waiting list control group
Number of subjects: 53
Study: 32532356

Group type: EXPERIMENTAL
Intervention: Intravenous injection of dental pulp stem cells suspension (3.0x10^7 human DPSCs in 30ml saline solution) on days 1, 4, and 7
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (placebo) on days 1, 4, and 7
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Routine treatment for COVID-19
Number of subjects: 20